Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) antibody and antigen (recombinant protein)
Diagnostic anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) antibodies pairs and antigen for animal health (animal Multiple species infectious disease ) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-VT-P274-Tg001-Ag01 | Recombinant Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) protein | 3090 |
GMP-VT-P274-Tg001-Ab01 | Anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) mouse monoclonal antibody (mAb) | 1953 |
GMP-VT-P274-Tg001-Ab02 | Anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) mouse monoclonal antibody (mAb) | 1953 |
GMP-VT-P274-Tg001-Ab03 | Anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) human monoclonal antibody (mAb) | 1953 |
GMP-VT-P274-Tg001-Ab04 | Anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-VT-P274-Tg001-Ag01 |
Product Name | Recombinant Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) protein |
Pathogen | Fowl Adenovirus (FAdV) |
Target/Biomarker | Ubiquitin-like-specific protease 1(ULP1) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Fowl Adenovirus (FAdV) Ubiquitin-like-specific protease 1(ULP1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Fowl Adenovirus (FAdV) level test of animal Multiple species with Saccharomyces cerevisiae infection. |
Tag | His |
Products description | Recombinant Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-VT-P274-Tg001-Ab01, GMP-VT-P274-Tg001-Ab02 |
Product Name | Anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) mouse monoclonal antibody (mAb) |
Pathogen | Fowl Adenovirus (FAdV) |
Target/Biomarker | Ubiquitin-like-specific protease 1(ULP1) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Fowl Adenovirus (FAdV) Ubiquitin-like-specific protease 1(ULP1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Fowl Adenovirus (FAdV) antibodies in Fowl Adenovirus (FAdV) level test of animal Multiple species with Saccharomyces cerevisiae infection. |
Tag | mFc |
Products description | Anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-VT-P274-Tg001-Ab03, GMP-VT-P274-Tg001-Ab04 |
Product Name | Anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) human monoclonal antibody (mAb) |
Pathogen | Fowl Adenovirus (FAdV) |
Target/Biomarker | Ubiquitin-like-specific protease 1(ULP1) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Fowl Adenovirus (FAdV) Ubiquitin-like-specific protease 1(ULP1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Fowl Adenovirus (FAdV) antibodies in Fowl Adenovirus (FAdV) level test of animal Multiple species with Saccharomyces cerevisiae infection. |
Tag | hFc |
Products description | Anti-Saccharomyces cerevisiae Ubiquitin-like-specific protease 1(ULP1) human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Saccharomyces cerevisiae causes Fungemia, endocarditis, pneumonia, peritonitis, urinary tract infections, skin infections, and esophagitis. It is important to consider infections due to S. cerevisiae in appropriate clinical settings
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.